跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 43,935 条关于
“CDK 4/6 inhibitors”
全部
43,935
临床试验
20,138
药物
9,444
机构
2,576
资讯
11,777
11年前
Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment
9年前
Ribociclib Shows Promise in Advanced Breast Cancer Treatment
去年
Advances in Immunotherapy and Precision Medicine Transform Endometrial Cancer Treatment
12个月前
Roche's Giredestrant Combination Meets Phase III Endpoints in Advanced Breast Cancer
去年
Puma Biotechnology Initiates Phase II Trial of Alisertib for HR+/HER2- Metastatic Breast Cancer
去年
Puma Biotechnology Initiates Phase II Trial of Alisertib for HR+/HER2- Metastatic Breast Cancer
去年
Puma Biotechnology Initiates Phase II Trial of Alisertib for HR+/HER2- Metastatic Breast Cancer
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
去年
Puma Biotechnology Initiates Phase II Trial of Alisertib for HR+/HER2- Metastatic Breast Cancer
去年
Puma Biotechnology Initiates Phase II Trial of Alisertib for HR+/HER2- Metastatic Breast Cancer
第 1 页,共 1178 页
上一页
下一页